|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
1,250,000,000 |
Market
Cap: |
132.41(B) |
Last
Volume: |
6,053,443 |
Avg
Vol: |
8,493,746 |
52
Week Range: |
$66.59 - $117.41 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
S&P COMPOSITE 1500 |
|
NASDAQ BIOTECHNOLOGY |
|
NASDAQ COMPOSITE |
|
NASDAQ-100 |
|
S&P 500 |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 425 |
Guru Rank Value : 4.8 |
Guru Occurances : 3 |
|
|
|
|
|
|
|
Company Profile Gilead Sciences is a research-based biopharmaceutical company that discovers, develops and commercializes medicines. Co.'s primary areas of focus include viral diseases, inflammatory diseases and oncology. Co.'s products include: Biktarvy® for the treatment of HIV-1 infection in certain patients; Veklury® (remdesivir), for the treatment of Coronavirus Disease 2019 requiring hospitalization; Epclusa® for the treatment of chronic hepatitis C virus infection; Vemlidy® for the treatment of chronic hepatitis B virus infection in adults with compensated liver disease; Yescarta® (axicabtagene ciloleucel) for the treatment of adult patients with relapsed or refractory large B-cell lymphoma.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
48,500 |
353,785 |
882,125 |
919,098 |
Total Sell Value |
$5,236,242 |
$36,015,844 |
$84,083,262 |
$87,021,111 |
Total People Sold |
3 |
3 |
5 |
5 |
Total Sell Transactions |
6 |
12 |
24 |
32 |
End Date |
2025-03-27 |
2024-12-24 |
2024-06-25 |
2023-06-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Dickinson Andrew D |
Chief Financial Officer |
|
2025-06-16 |
4 |
AS |
$110.17 |
$275,425 |
D/D |
(2,500) |
165,110 |
|
-2% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-06-16 |
4 |
AS |
$110.17 |
$330,510 |
D/D |
(3,000) |
120,168 |
|
-2% |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-06-10 |
4 |
D |
$110.09 |
$193,538 |
D/D |
(1,758) |
167,610 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,694 |
169,368 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-06-10 |
4 |
D |
$110.09 |
$546,927 |
D/D |
(4,968) |
625,725 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,425 |
630,693 |
|
- |
|
Wilfong Diane E |
Interim Corp Controller & CAO |
|
2025-06-10 |
4 |
D |
$110.09 |
$37,431 |
D/D |
(340) |
45,676 |
|
- |
|
Wilfong Diane E |
Interim Corp Controller & CAO |
|
2025-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
920 |
46,016 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-06-10 |
4 |
D |
$110.09 |
$47,339 |
D/D |
(430) |
37,801 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,313 |
38,231 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-06-10 |
4 |
D |
$110.09 |
$201,134 |
D/D |
(1,827) |
123,168 |
|
- |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-06-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,843 |
124,995 |
|
- |
|
Oday Daniel Patrick |
Chairman & CEO |
|
2025-05-30 |
4 |
AS |
$110.11 |
$1,104,193 |
D/D |
(10,000) |
620,268 |
|
-1% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-05-22 |
4 |
AS |
$107.52 |
$3,010,564 |
D/D |
(28,000) |
121,152 |
|
2% |
|
Mercier Johanna |
Chief Commercial Officer |
|
2025-05-22 |
4 |
OE |
$66.64 |
$1,666,000 |
D/D |
25,000 |
136,652 |
|
- |
|
Dickinson Andrew D |
Chief Financial Officer |
|
2025-05-15 |
4 |
AS |
$99.82 |
$249,550 |
D/D |
(2,500) |
165,674 |
|
8% |
|
Horning Sandra |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
5,147 |
|
- |
|
Barton Jacqueline K |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
26,056 |
|
- |
|
Welters Anthony |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
11,748 |
|
- |
|
Rodriguez Javier |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
12,218 |
|
- |
|
Love Ted W |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
4,338 |
|
- |
|
Manwani Harish |
Director |
|
2025-05-07 |
4 |
D |
$98.90 |
$29,274 |
D/D |
(296) |
14,093 |
|
- |
|
Manwani Harish |
Director |
|
2025-05-07 |
4 |
A |
$0.00 |
$0 |
D/D |
1,516 |
14,389 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-04-25 |
4 |
D |
$103.17 |
$16,301 |
D/D |
(158) |
36,918 |
|
- |
|
Telman Deborah H |
EVP, Corporate Affairs & GC |
|
2025-04-25 |
4 |
OE |
$0.00 |
$0 |
D/D |
514 |
37,076 |
|
- |
|
978 Records found
|
|
Page 1 of 40 |
|
|